PCM
KDNY

PenderFund Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

PenderFund Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,480
Closed -$839K – 142
2023
Q2 		$839K Buy
+16,480
New +$839K 0.26% 62